Impact of High-Efficacy Therapies for Multiple Sclerosis on B Cells

Impact of High-Efficacy Therapies for Multiple Sclerosis on B Cells

Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative autoimmune disorder of the central nervous system characterized by demyelination and neurodegeneration. Traditionally considered a T-cell-mediated disease, the crucial role of B lymphocytes in its pathogenesis, through different...

Full description

Saved in:
Bibliographic Details
Main Authors: Federica Galota, Simone Marcheselli, Sara De Biasi, Lara Gibellini, Francesca Vitetta, Alessia Fiore, Krzysztof Smolik, Giulia De Napoli, Martina Cardi, Andrea Cossarizza, Diana Ferraro
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Cells
Subjects:
multiple sclerosis
high-efficacy therapies
B cells
disease-modifying therapies (DMTs)
anti-CD20
Alemtuzumab
Online Access:https://www.mdpi.com/2073-4409/14/8/606
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2073-4409/14/8/606

Similar Items